Logo image
LNCRNA 1197 Promotes the Progression of Fibroblast-Like Synovial Cells by Targeting miR-206 in Rheumatoid Arthritis Patients: A Pilot Study
Journal article   Peer reviewed

LNCRNA 1197 Promotes the Progression of Fibroblast-Like Synovial Cells by Targeting miR-206 in Rheumatoid Arthritis Patients: A Pilot Study

Xiang Lu, Shanle Yan, Xiaoli Li, Yuan Xue and Liyun Zhang
Annals of clinical and laboratory science, Vol.54(5), pp.588-596
09/2024
PMID: 39537234

Abstract

Arthritis, Rheumatoid - genetics Arthritis, Rheumatoid - metabolism Arthritis, Rheumatoid - pathology Cell Movement - genetics Cell Proliferation - genetics Cells, Cultured Disease Progression Female Fibroblasts - metabolism Fibroblasts - pathology Humans MicroRNAs - genetics MicroRNAs - metabolism Pilot Projects RNA, Long Noncoding - genetics RNA, Long Noncoding - metabolism Synovial Membrane - metabolism Synovial Membrane - pathology Synoviocytes - metabolism Synoviocytes - pathology
We studied the role of LNCRNA 1197 in rheumatoid arthritis (RA) and its underlying mechanism. We detected expression of LNCRNA 1197 in RA fibroblast-like synovial cells (RA-FLS) by RT-qPCR. Functional experiments were conducted to assess the impact of LNCRNA on cells as demonstrated by a Transwell assay. In addition, Western blot analysis was conducted to analyze the expression of proliferation-related proteins and flow cytometry and CCK-8 to analyze cell cycle and cell proliferation. We also identified the potential downstream target miRNA of LNCRNA 1197. LNCRNA 1197 was highly expressed in RA-FLS. When LNCRNA 1197 was knocked down, the cell proliferation, migration, and invasion of RA-FLS were alleviated, and pro-inflammatory cytokines were significantly downregulated. Interestingly, LNCRNA 1197 was indicated to target miR-206 and promoted progression of FLS by inhibiting miR-206. Taken altogether, LNCRNA 1197 promotes the progression of RA-FLSs by miR-206 inhibition.

Metrics

1 Record Views

Details

Logo image